Pharma Eyes Psychedelics Market as Patients Seek New Depression Treatments

| (NaturalNews) Eli Lilly's multibillion-dollar acquisition of a company developing experimental psychedelic therapies marks the largest investment yet by a drugmaker... |
💡 AI analysis provides alternative perspectives on current events